Published in J Pharmacol Exp Ther on June 01, 1970
The effects of some phosphodiesterase inhibitors on the conductance of the perfused vascular beds of the chloralosed cat. Br J Pharmacol (1972) 0.80
Desferrioxamine B, an inhibitor of Escherichia coli motility, reversing the stimulating effect of cyclic adenosine 3',5'-monophosphate. Antimicrob Agents Chemother (1975) 0.76
Agar plate screening procedure for cyclic adenosine 3',5'-monophosphate and inhibitors of cyclic nucleotide phosphodiesterase. Appl Environ Microbiol (1977) 0.75
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. N Engl J Med (1995) 3.86
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis (2012) 2.52
Community outbreak of psittacosis in a rural Australian town. Lancet (1998) 2.30
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler (2004) 2.15
Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times. Magn Reson Imaging (2002) 1.80
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses (1999) 1.66
PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. J Clin Microbiol (2000) 1.53
A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection. J Infect Dis (1995) 1.46
Paediatric day stay tonsillectomy service: development and audit. Anaesth Intensive Care (2002) 1.46
Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol (1997) 1.45
The stimulation of adenyl cyclase of rat erythrocyte ghosts. Mol Pharmacol (1970) 1.43
Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr (2001) 1.41
Spontaneous noncardiac chest pain. Evaluation by 24-hour ambulatory esophageal motility and pH monitoring. Gastroenterology (1988) 1.38
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J Infect Dis (2001) 1.34
Home collection for frequent HIV testing: acceptability of oral fluids, dried blood spots and telephone results. HIV Early Detection Study Group. AIDS (2000) 1.32
Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem (2000) 1.29
A South Australian Salmonella Mbandaka outbreak investigation using a database to select controls. Aust N Z J Public Health (1998) 1.25
Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil). J Antimicrob Chemother (2001) 1.20
Strong and macroporous calcium phosphate cement: Effects of porosity and fiber reinforcement on mechanical properties. J Biomed Mater Res (2001) 1.17
Adenosine-mediated elevation of cyclic 3':5'-adenosine monophosphate concentrations in cultured mouse neuroblastoma cells. Proc Natl Acad Sci U S A (1973) 1.17
Wear and mechanical properties of nano-silica-fused whisker composites. J Dent Res (2004) 1.17
Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase. Mol Pharmacol (1971) 1.12
Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study. J Infect Dis (2003) 1.11
Automated colorimetric determination of free fatty acids in biologic fluids. Clin Chem (1967) 1.10
Processing and properties of strong and non-rigid calcium phosphate cement. J Dent Res (2002) 1.05
Different sensitivities of the phosphodiesterases (adenosine-3',5'-cyclic phosphate 3'-phosphohydrolase) of dog cerebral cortex and erythrocytes to inhibition by synthetic agents and cold. Biochem Pharmacol (1971) 1.04
Vertically transmitted babesiosis. J Pediatr (1997) 0.99
Adenyl cyclase in non-nucleated erythrocytes of several mammalian species. Biochem Pharmacol (1969) 0.98
An AC electroosmotic micropump for circular chromatographic applications. Lab Chip (2004) 0.97
On the brittleness of enamel and selected dental materials. Dent Mater (2008) 0.97
The effect of rehabilitation at different stages of development of rats marginally malnourished for ten to twelve generations. Br J Nutr (1980) 0.95
Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease. J Neurol Neurosurg Psychiatry (2008) 0.95
Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party. Ann Intern Med (1996) 0.94
Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues. Adv Cyclic Nucleotide Res (1972) 0.93
Operation Safe Haven: an evaluation of health surveillance and monitoring in an acute setting. Commun Dis Intell (2000) 0.90
Inhibition of platelet aggregation by papaverine-like drugs: evidence for a novel mechanism of action. Biochem Pharmacol (1976) 0.90
Cyclic AMP regulation of prostaglandin biosynthesis in fat cells. Prostaglandins (1974) 0.88
Calcium balance in children treated with diphosphonates. Arch Dis Child (1975) 0.88
The skin reservoir of sulphur mustard. Toxicol In Vitro (2008) 0.87
The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. J Neurol Neurosurg Psychiatry (2003) 0.87
Concentration of endometrial protein PP14 in uterine flushings throughout the menstrual cycle in normal, fertile women. Br J Obstet Gynaecol (1993) 0.86
Biochemical changes observed in desoxycorticosterone acetate (DOCA)-hypertensive rats. Trans N Y Acad Sci (1966) 0.85
A prolonged outbreak of Campylobacter infection at a training facility. Commun Dis Intell (1997) 0.84
Increase of cyclic GMP induced in murine thymocytes by thymosin fraction 5. Biochem Biophys Res Commun (1976) 0.84
Inhibition of norepinephrine stimulated adenyl cyclase by theophylline. Nature (1970) 0.83
Early effect of 25-hydroxycholecalciferol (25-OH-D3) and 1,25-dihydroxycholecalciferol (1,25-(OH)2-D3) on the ability of parathyroid hormone (PTH) to elevate cyclic AMP of intact bone cells. Biochem Biophys Res Commun (1975) 0.83
Hypoplasia of the epiglottis: case report and review. Int J Pediatr Otorhinolaryngol (1996) 0.82
Inability of prostaglandin synthesis inhibitors to affect adipose tissue lipolysis. Prostaglandins (1973) 0.82
Placental protein 14 levels in uterine flushing and plasma of women with unexplained infertility. Fertil Steril (1993) 0.82
Fresh garlic: a possible vehicle for Salmonella Virchow. Epidemiol Infect (2003) 0.81
Variable responses of human platelets to synthetic platelet activating factor and their modification by epinephrine. Thromb Res (1982) 0.81
Gallium 67 scanning in rheumatoid arthritis. Br J Radiol (1983) 0.81
Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler (2002) 0.81
Angiotensin antagonism and antihypertensive activity of phosphodiesterase inhibiting agents. Life Sci I (1973) 0.80
Hypothalamic and hypophyseal estradiol-binding complexes. Endocrinology (1971) 0.79
The effect of pH and hypertonic KC1 on the collection of the cyclic AMP-protein complex from rat skeletal muscle and erythrocyte extracts. Life Sci (1975) 0.79
Whisker-reinforced bioactive composites containing calcium phosphate cement fillers: effects of filler ratio and surface treatments on mechanical properties. J Biomed Mater Res (2001) 0.79
The effect of alpha, beta, and dopamine receptor-blocking agents on the stimulation of rat erythrocyte adenyl cyclase by dihydroxyphenethylamines and their beta-hydroxylated derivatives. Mol Pharmacol (1971) 0.78
3-Phenyl-5-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]indole-2-carbonitrile, a potent inhibitor of prostaglandin synthetase and of platelet aggregation. J Med Chem (1979) 0.78
An analysis of the variation of plasma concentrations of placental protein 14 in artificial cycles. Fertil Steril (1992) 0.78
Effect of tetrahydroisoquinoline derivatives on the adenylate cyclases of the caudate nucleus (dopamine-type) and erythrocyte (beta-type) of the rat. Res Commun Chem Pathol Pharmacol (1974) 0.78
Laryngoscopic diagnosis of laryngeal sarcoid. Ann Otol Rhinol Laryngol (1995) 0.78
Taking back their health care. Newsweek (1994) 0.77
Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses. Clin Infect Dis (1995) 0.77
The correlation of placental protein 14 concentrations in uterine flushing and endometrial morphology in the peri-implantation period. Hum Reprod (1993) 0.77
Effect of biotin and ascorbic acid on the development of atherosclerosis in rabbits. Atherosclerosis (1972) 0.76
Influence of dietary vitamin E on prostaglandin biosynthesis in rat blood. Prostaglandins (1975) 0.76
The effects of psychological and environmental stressors on peristaltic esophageal contractions in healthy volunteers. Psychophysiology (1987) 0.76
Prostaglandin inhibition of cyclic-AMP accumulation and rate of lipolysis in fat cells. Prostaglandins (1974) 0.76
The influence of NADPH on the hydroxylation of progesterone by rat adrenal homogenates. Life Sci (1966) 0.76
Protein expression profiling of normal and neoplastic canine prostate and bladder tissue. Vet Comp Oncol (2007) 0.76
The lack of correlation between inhibition of aggregation and cAMP levels with canine platelets. Thromb Res (1982) 0.76
Alterations in the hydrolytic activity, inhibitor sensitivity and molecular size of the rat erythrocyte cyclic AMP phosphodiesterase by calcium and hypertonic sodium chloride. J Cyclic Nucleotide Res (1975) 0.76
Unexpected beneficial effects of measles immunisation. Measles vaccination may be marker for other health seeking behaviours. BMJ (2000) 0.75
Recent developments in selenium research. Br J Biomed Sci (2009) 0.75
Age-dependent changes in the adenylate cyclase and phosphodiesterase activity of rat erythrocytes. Biochem Pharmacol (1973) 0.75
Insurance: the death spiral. Newsweek (1993) 0.75
Norway: Small Country Plans Civil Science and Technology: Experience suggests how cooperative applied science programs can be linked to national goals and needs. Science (1974) 0.75
National Planning of Science and Technology in France. Science (1965) 0.75
A new war on health costs. Newsweek (1984) 0.75
Pharmacologic and biochemical evaluation of organic nitrates: attempted correlation of activities. J Pharmacol Exp Ther (1971) 0.75
Regulation of hormone stimulation of adipose tissue lipolysis by guanosine triphosphate. Arch Biochem Biophys (1974) 0.75
Financing long-term care. The choice: better insurance or more taxes. Newsweek (1989) 0.75
Health reform: the missing story. Critics in fright wigs mislead you about the Clinton plan. Newsweek (1994) 0.75
Shopping for health care. Newsweek (1982) 0.75
Family obligations. Newsweek (1983) 0.75
Paying for universal care. Newsweek (1993) 0.75
Health care cooperation at Aquarius Festival. Med J Aust (1974) 0.75
Regional cyclic nucleotide phosphodiesterase activity in cat central nervous system: effects of benzodiazepines. Proc Soc Exp Biol Med (1974) 0.75
Serum lipid-lowering properties of 6-chloro-9-[2-(6-methyl-3-pyridyl)ethyl]-1,2,3,4-tetrahydrocarbazole-2-carboxylic acid. J Pharm Sci (1977) 0.75
Surgery for medical costs. Newsweek (1983) 0.75
When health plans fail. Newsweek (1992) 0.75
Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs. Biochem Pharmacol (1974) 0.75
Lost: another health benefit. When you retire, your blanket plan may be buried wherever the boss's promises go to die. Newsweek (1991) 0.75
Trimethoquinol-different pharmacological properties of optical isomers. Biochem Pharmacol (1976) 0.75